{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+Administration+first&page=8", "query": { "intervention": "Placebo Administration first", "page": 8 }, "page_size": 10 }, "pagination": { "page": 8, "page_size": 10, "total_count": 1736, "total_pages": 174, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+Administration+first&page=9&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+Administration+first&page=7&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-15T11:45:20.401Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05832229", "title": "Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cirrhosis", "Cirrhosis, Liver", "Cirrhosis Early", "Cirrhosis Due to Hepatitis B", "Cirrhosis Advanced", "Cirrhosis Infectious", "Cirrhosis Alcoholic", "Cirrhosis Due to Hepatitis C" ], "interventions": [ { "name": "Rosuvastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 260, "start_date": "2023-12-07", "completion_date": "2029-08-31", "has_results": false, "last_update_posted_date": "2026-09-28", "last_synced_at": "2026-11-15T11:45:20.401Z", "location_count": 13, "location_summary": "La Jolla, California • Los Angeles, California • San Francisco, California + 7 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05832229" }, { "nct_id": "NCT04898036", "title": "Phototherapy For Treatment Of Raynaud's Phenomenon", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Raynaud Disease", "Raynaud Phenomenon", "Raynaud Syndrome" ], "interventions": [ { "name": "Blue Light Therapy", "type": "DEVICE" }, { "name": "Sham Light Therapy", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 0, "start_date": "2022-08", "completion_date": "2023-03", "has_results": false, "last_update_posted_date": "2023-01-06", "last_synced_at": "2026-11-15T11:45:20.401Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT04898036" }, { "nct_id": "NCT00225732", "title": "Trial of Caldolor for Treatment of Pain in Post-Operative Adult Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pain" ], "interventions": [ { "name": "Normal saline as placebo comparator", "type": "OTHER" }, { "name": "Intravenous ibuprofen", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "Cumberland Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "FEMALE", "summary": "18 Years to 70 Years · Female only" }, "enrollment_count": 319, "start_date": "2005-01", "completion_date": "2008-01", "has_results": true, "last_update_posted_date": "2016-06-22", "last_synced_at": "2026-11-15T11:45:20.401Z", "location_count": 12, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Montgomery, Alabama + 6 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00225732" }, { "nct_id": "NCT01120184", "title": "A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "docetaxel", "type": "DRUG" }, { "name": "paclitaxel", "type": "DRUG" }, { "name": "pertuzumab", "type": "DRUG" }, { "name": "pertuzumab-placebo", "type": "DRUG" }, { "name": "trastuzumab [Herceptin]", "type": "DRUG" }, { "name": "trastuzumab emtansine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1095, "start_date": "2010-07-31", "completion_date": "2016-09-16", "has_results": true, "last_update_posted_date": "2024-03-04", "last_synced_at": "2026-11-15T11:45:20.401Z", "location_count": 62, "location_summary": "Little Rock, Arkansas • La Jolla, California • Montebello, California + 55 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "La Jolla", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Montebello", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01120184" }, { "nct_id": "NCT01332552", "title": "A First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2485852 in Chronically Infected Hepatitis C Subjects", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hepatitis C" ], "interventions": [ { "name": "GSK2485852 70 mg", "type": "DRUG" }, { "name": "GSK2485852 420 mg", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" }, { "name": "GSK2485852 630 mg", "type": "DRUG" }, { "name": "GSK2485852 70 mg + Ritonavir 100mg", "type": "DRUG" }, { "name": "GSK2485852 210 mg +Ritonavir 100mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 27, "start_date": "2011-01-14", "completion_date": "2011-04-06", "has_results": false, "last_update_posted_date": "2017-07-07", "last_synced_at": "2026-11-15T11:45:20.401Z", "location_count": 5, "location_summary": "Anaheim, California • Orlando, Florida • Lenexa, Kansas + 2 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Orlando", "state": "Florida" }, { "city": "Lenexa", "state": "Kansas" }, { "city": "Las Vegas", "state": "Nevada" }, { "city": "Willingboro", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT01332552" }, { "nct_id": "NCT05503264", "title": "A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "NMDAR Autoimmune Encephalitis", "LGI1 Autoimmune Encephalitis" ], "interventions": [ { "name": "Satralizumab", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 122, "start_date": "2022-09-27", "completion_date": "2028-12-14", "has_results": false, "last_update_posted_date": "2026-10-08", "last_synced_at": "2026-11-15T11:45:20.401Z", "location_count": 11, "location_summary": "Birmingham, Alabama • Newport Beach, California • San Francisco, California + 7 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Newport Beach", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05503264" }, { "nct_id": "NCT01605617", "title": "Trial of Percutaneous Tibial Nerve Stimulation (PTNS) Versus PTNS and Fesoterodine Fumarate", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Overactive Bladder" ], "interventions": [ { "name": "Fesoterodine fumarate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Percutaneous Tibial Nerve Stimulation (PTNS)", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 4, "start_date": "2012-06", "completion_date": "2013-03", "has_results": true, "last_update_posted_date": "2014-02-05", "last_synced_at": "2026-11-15T11:45:20.401Z", "location_count": 1, "location_summary": "Phoenix, Arizona", "locations": [ { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01605617" }, { "nct_id": "NCT00521196", "title": "Migraine--Investigational Treatment of Migraine With Noninvasive Brain Stimulation. (tDCS- Migraine)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Migraine" ], "interventions": [ { "name": "DC Stimulator (Transcranial Direct Current Stimulator)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Beth Israel Deaconess Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 13, "start_date": "2007-07", "completion_date": "2012-01-13", "has_results": false, "last_update_posted_date": "2017-03-21", "last_synced_at": "2026-11-15T11:45:20.401Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00521196" }, { "nct_id": "NCT01848158", "title": "Acupuncture to Improve Comfort of Children on a Ventilator in the Intensive Care Unit", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Agitation" ], "interventions": [ { "name": "acupuncture", "type": "DEVICE" }, { "name": "sham acupuncture", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Seattle Children's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Months to 17 Years" }, "enrollment_count": 17, "start_date": "2013-03", "completion_date": "2016-06", "has_results": true, "last_update_posted_date": "2020-08-13", "last_synced_at": "2026-11-15T11:45:20.401Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01848158" }, { "nct_id": "NCT01772693", "title": "ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Parkinson's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Parkinson's Disease" ], "interventions": [ { "name": "ExAblate Transcranial MRgFUS", "type": "DEVICE" }, { "name": "Sham ExAblate Transcranial MRgFUS", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "InSightec", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 27, "start_date": "2012-09", "completion_date": "2019-03", "has_results": true, "last_update_posted_date": "2020-10-09", "last_synced_at": "2026-11-15T11:45:20.401Z", "location_count": 2, "location_summary": "Charlottesville, Virginia • Seattle, Washington", "locations": [ { "city": "Charlottesville", "state": "Virginia" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01772693" } ] }